MENU
+Compare
AGYTF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$0.05
Change
-$0.01 (-16.67%)
Capitalization
25.84M

AGYTF Allergy Therapeutics Plc. Forecast, Technical & Fundamental Analysis

AGYTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for AGYTF with price predictions
Dec 18, 2024

Momentum Indicator for AGYTF turns positive, indicating new upward trend

AGYTF saw its Momentum Indicator move above the 0 level on November 26, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator turned positive. In of the 34 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for AGYTF just turned positive on December 03, 2024. Looking at past instances where AGYTF's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

AGYTF moved below its 50-day moving average on November 12, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AGYTF crossed bearishly below the 50-day moving average on November 12, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for AGYTF entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGYTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.482) is normal, around the industry mean (57.958). P/E Ratio (49.261) is within average values for comparable stocks, (89.727). AGYTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.416) is also within normal values, averaging (19.472).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGYTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
AGYTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Dominion Way
Phone
+44 1903844700
Employees
622
Web
https://www.allergytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMMU49.96-0.07
-0.13%
PIMCO Short Term Municipal Bond Actv ETF
MBBB21.33-0.18
-0.83%
VanEck Mdy's Aly BBB Corp Bd ETF
ALTL37.12-0.77
-2.03%
Pacer Lunt Large Cap Alternator ETF
DVOL33.68-0.82
-2.37%
FirstTrustDorseyWrightMomt&LwVolatil ETF
VOX156.17-4.62
-2.87%
Vanguard Communication Services ETF

AGYTF and Stocks

Correlation & Price change

A.I.dvisor tells us that AGYTF and SGIOF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGYTF and SGIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGYTF
1D Price
Change %
AGYTF100%
N/A
SGIOF - AGYTF
25%
Poorly correlated
N/A
SDZXF - AGYTF
20%
Poorly correlated
N/A
PRFX - AGYTF
11%
Poorly correlated
-17.18%
APNHY - AGYTF
4%
Poorly correlated
+4.91%
ORGO - AGYTF
3%
Poorly correlated
-9.24%
More